Use of conventional bioanalytical devices to automate DBS extractions in liquid-handling dispensing tips

Bioanalysis

Volumn 3, Issue 20, 2011, Pages 2303-2310

  Johnson, Casey J L ^a   Christianson, Chad D ^a   Sheaff, Chrystal N ^a   Laine, Derek F ^a   Zimmer, Jennifer S D ^a   Needham, Shane R ^a  

^a Alturas Analytics Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYALPRAZOLAM; ALPHA HYDROXYALPRAZOLAM D5; ALPRAZOLAM; ALPRAZOLAM D5; MIDAZOLAM; MIDAZOLAM D4; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; AUTOMATION; BLOOD ANALYSIS; CONTROLLED STUDY; DEVICE; DRIED BLOOD SPOT; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID HANDLING DEVICE; MATHEMATICAL ANALYSIS; TANDEM MASS SPECTROMETRY;

ALPRAZOLAM; AUTOMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRIED BLOOD SPOT TESTING; HUMANS; MIDAZOLAM; TANDEM MASS SPECTROMETRY;

EID: 80054863745     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.212     Document Type: Article

References (17)

1. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24(1), 49-65 (2010).
2. Christianson C, Laine D, Zimmer J et al. Development and validation of an HPLC-MS/MS method for the analysis of dexamethasone from pig synovial fluid using dried matrix spotting. Bioanalysis 2(11), 1829-1837 (2010).
3. Abu-Rabie P, Spooner N. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface. Anal. Chem. 81(24), 10275-10284 (2009).
4. nProvides an example of a validated bioanalytical dried blood spot (DBS) method and outlines the use of a color-indicating dye solution for internal standard addition. 3 Abu-Rabie P, Spooner N. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface. Anal. Chem. 81(24), 10275-10284 (2009). 4 Heine RT, Rosing H, van Gorp EC et al. Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. J. Chromatogr. B. 867(2), 205-212 (2008).
5. Déglon J, Lauer E, Thomas A et al. Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine and paroxetine analysis. Anal. Bioanal. Chem. 396(7), 2523-2532 (2010).
6. Spooner N, Rakesh L, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81(4), 1557-1563 (2009).
7. Liang X, Li Y, Barfield M et al. Study of dried blood spot technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J. Chromatogr. B. 877(8-9), 799-806 (2009).
8. Rowland M, Emmons G. Use of dried blood spots in drug development: pharmacokinetic considerations. AAPS J. 12(3), 290-293 (2010).
9. Edelbroek P, Heijden J, Stolk L. Dried blood spot methods in therapeutic drug monitoring: methods, assays and pitfalls. Ther. Drug Monit. 31(3), 327-336 (2009).
10. McDade T, Williams S, Snodgrass J. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44(4), 899-925 (2007).
11. Wong P, Pham R, Bruenner B et al. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis. Bioanalysis 2(11), 1787-1789 (2010).
12. Beharry M. DBS: a UK (MHRA) regulatory perspective. Bioanalysis 2(8), 1363-1364 (2010).
13. Greenblatt D, Wright C. Clinical pharmacokinetics of alprazolam. Therapeutic implications. Clin. Pharmacokinet. 24(6), 453-471 (1993). (Pubitemid 23160615)
14. Christianson C, Needham S, Zimmer J. Validation of an HPLC-MS/MS bioanalytical method for the quantitative analysis of alprazolam, a-OH-alprazolam and 4-OH-alprazolam in human plasma. Presented at: The American Society of Mass Spectrometry Conference. Salt Lake City, UT, USA, 18 May 2006.
15. Christianson C, Needham S, Zimmer J. Validation of an HPLC-MS/MS bioanalytical method for the quantitative analysis of alprazolam, a-OH-alprazolam and 4-OH-alprazolam in human plasma. Presented at: The American Society of Mass Spectrometry Conference. Salt Lake City, UT, USA, 18 May 2006. 15 Dundee J, Halliday N, Harper K et al. A review of its pharmacological properties and therapeutic use. Drugs 28(6), 519-543 (1986).
16. Oldenhof H, de Jong M, Steenhoek A et al. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin. Pharmacol. Ther. 43(3), 263-269 (1988). (Pubitemid 18091847)
17. Snyder L, Kirkland J, Glajch J. Practical HPLC Method Development (2nd Edition). John Wiley & Sons, Inc., NY, USA, 47-49 (1997).